Evidence map›Paper›PMID 35440905›Full record

ArticleJournal of the Medical Library Association : JMLA2022

Patient-based benefit-risk assessment of medicines: development, refinement, and validation of a content search strategy to retrieve relevant studies.

Hiba El Masri, Treasure M McGuire, Christine Dalais, Mieke van Driel, Helen Benham, Samantha A Hollingworth

Abstract read
In one paragraph

Article in Journal of the Medical Library Association : JMLA, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hiba El Masrih.elmasri@uqconnect.edu.au, PhD Candidate, School of Pharmacy, The University of Queensland, Woolloongabba, QLD, Australia.ORCID 0000-0003-4894-6148
Treasure M McGuiret.mcguire@uq.edu.au, Faculty of Health Sciences and Medicine, Bond University, Robina, QLD, Australia, Mater Pharmacy, Mater Health, Raymond Tce, South Brisbane, QLD, Australia.ORCID 0000-0003-1417-7037
Christine Dalaisc.dalais@library.uq.edu.au, University Library, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0001-7534-4041
Mieke van Drielm.vandriel@uq.edu.au, Primary Care Clinical Unit, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0003-1711-9553
Helen Benhamh.benham@uq.edu.au, Department of Rheumatology, Princess Alexandra Hospital, Brisbane, QLD, Australia.ORCID 0000-0003-2361-3718
Samantha A Hollingworths.hollingworth@uq.edu.au, School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0002-5226-5663

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Poor indexing and inconsistent use of terms and keywords may prevent efficient retrieval of studies on the patient-based benefit-risk assessment (BRA) of medicines. We aimed to develop and validate an objectively derived content search strategy containing generic search terms that can be adapted for any search for evidence on patient-based BRA of medicines for any therapeutic area. Methods: We used a robust multistep process to develop and validate the content search strategy: (1) we developed a bank of search terms derived from screening studies on patient-based BRA of medicines in various therapeutic areas, (2) we refined the proposed content search strategy through an iterative process of testing sensitivity and precision of search terms, and (3) we validated the final search strategy in PubMed by firstly using multiple sclerosis as a case condition and secondly computing its relative performance versus a published systematic review on patient-based BRA of medicines in rheumatoid arthritis. Results: We conceptualized a final search strategy to retrieve studies on patient-based BRA containing generic search terms grouped into two domains, namely the patient and the BRA of medicines (sensitivity 84%, specificity 99.4%, precision 20.7%). The relative performance of the content search strategy was 85.7% compared with a search from a published systematic review of patient preferences in the treatment of rheumatoid arthritis. We also developed a more extended filter, with a relative performance of 93.3% when compared with a search from a published systematic review of patient preferences in lung cancer.

Indexed as

Arthritis, RheumatoidHumansMEDLINEPubMedRisk Assessmentattribute developmentbenefit-risk assessmentbibliographicdatabasesinformation storage and retrieval/methodsinformation storage and retrieval/standardsMedical Subject Headingspatient-based benefit-risk assessmentpatient preferenceprescription drugreproducibility of resultsrisk assessment/methodsterminology as topic

Identifiers

PMID35440905
PMCPMC9014953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.